Takayuki Ishikawa
Fortune : 1 M $ au 31/07/2026
Fortune : 1 M $ au 31/07/2026
Takayuki Ishikawa currently works at JC Alliance KK, as Director from 2012.
Mr. Ishikawa also formerly worked at Japan Animal Referral Medical Center Co., Ltd., as Outside Director from 2008 to 2011, Japan Animal Referral Medical Center Co., Ltd., as Director & Administration Manager in 2014, and Yasuda Enterprise Development Co. Ltd., as Principal.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2025 | 188 500 ( 1,31% ) | 1 M $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
JC Alliance KK | Directeur/Membre du Conseil | 01/06/2012 |
| Sociétés | Poste | Fin |
|---|---|---|
| JAPAN ANIMAL REFERRAL MEDICAL CENTER CO., LTD. | Directeur/Membre du Conseil | 01/05/2011 |
Yasuda Enterprise Development Co. Ltd.
Yasuda Enterprise Development Co. Ltd. Investment ManagersFinance YED invests in early- and expansion-stages businesses in Asia, Europe and the US, across sectors including ICT, electronics devices and life sciences. Their investment strategy focuses on growing companies across expansion stages and with IPO and M&A potential. The firm invests in companies based on distinctive technology, favoring start-up and early-stage businesses. YED targets emerging firms with cutting edge technology in the medical device and biotechnology area, as well as in the IT sector. They focus on Japan, the US, Taiwan and Europe and favor businesses with the potential to penetrate global markets. The firm's preferred type of financing includes direct equity, convertible bonds and warrants. | Private Equity Investor | 20/12/2007 |
| JAPAN ANIMAL REFERRAL MEDICAL CENTER CO., LTD. | Directeur Administratif | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Yasuda Enterprise Development Co. Ltd.
Yasuda Enterprise Development Co. Ltd. Investment ManagersFinance YED invests in early- and expansion-stages businesses in Asia, Europe and the US, across sectors including ICT, electronics devices and life sciences. Their investment strategy focuses on growing companies across expansion stages and with IPO and M&A potential. The firm invests in companies based on distinctive technology, favoring start-up and early-stage businesses. YED targets emerging firms with cutting edge technology in the medical device and biotechnology area, as well as in the IT sector. They focus on Japan, the US, Taiwan and Europe and favor businesses with the potential to penetrate global markets. The firm's preferred type of financing includes direct equity, convertible bonds and warrants. | Finance |
Japan Animal Referral Medical Center Co., Ltd.
Japan Animal Referral Medical Center Co., Ltd. Agricultural Commodities/MillingProcess Industries Operates an animal hospital | Process Industries |
JC Alliance KK |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national